Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai Meiyue Biotech Development patents pantetheinase inhibitors

April 19, 2022

New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science

April 19, 2022

Medshine Discovery presents new PTPN11 inhibitors

April 19, 2022

New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics

April 19, 2022

Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors

April 19, 2022

INBRX-130: a novel bispecific antibody targeting 5T4 and CD3

April 19, 2022

Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer

April 19, 2022

New platform for rapid development of patient-specific APECs for ovarian carcinoma

April 19, 2022

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

April 19, 2022

Insilico Medicine nominates USP1 small-molecule inhibitor as preclinical candidate

April 14, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...